HCA Healthcare warned that full-year 2026 profits would land at the low end of its prior range after Hurricanes Helene and Milton disrupted operations, forcing procedure cancellations, facility repairs, and an estimated $200–300 million combined hit in lost revenue and extra costs. This update, referenced in early-to-mid April reports and analyst commentary, has kept pressure on the stock by highlighting near-term margin and volume risks even as the company maintains longer-term resiliency programs. The move builds on that earlier announcement and coincides with a recent Robert W. Baird price target cut (from $450 to $442, neutral rating issued mid-week), adding to concerns ahead of Q1 2026 earnings on April 24. High trading volume on recent down days reflects investors repositioning on these quantifiable headwinds. (No major new company-specific release appears tied precisely to the April 17 premarket window.)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.